JP Morgan Chase’s Jaguar Health JAGX Stock Holding History
Bought
Maintained
Sold
Other funds holding JAGX
PCM
TRCT
JP Morgan Chase's JAGX Position: Q2 2024 in Review
JP Morgan Chase held its Jaguar Health (JAGX) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7564.
JP Morgan Chase first reported a position in JAGX in Q3 2023 and has held it in 2 quarters since. The position peaked at $24.8K in Q4 2023. 6 funds tracked by Wall St. Rank hold JAGX as of Q2 2024.
- JP Morgan Chase held 0 shares of Jaguar Health worth $0 as of Q2 2024.
- JP Morgan Chase left its Jaguar Health share count unchanged in Q2 2024.
- Jaguar Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2024, its #7564 holding.
- JP Morgan Chase first reported a position in Jaguar Health in Q3 2023 and has held it in 2 quarters since.
- JP Morgan Chase's Jaguar Health position peaked at $24.8K in Q4 2023.
- 6 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2024.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.